Histopathological diagnosis of hepatocellular carcinoma

Czech version

Authors: E. Honsová
Authors‘ workplace: Pracoviště klinické a transplantační patologie, Transplantcentrum IKEM, Praha
Published in: Gastroent Hepatol 2012; 66(2): 93-98
Category: Hepatology: Best Practises

Sources

1. International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49(2): 658–664.

2. Filmus J. Glypican in growth control and cancer. Glycobiology 2001; 11(3): 19–23.

3. Takai H, Kato A, Ishiguro T et al. Optimization of tissue processing for immunohitochemistry for the detection of human glypican-3. Acta Histochem 2010; 112(3): 240–250.

4. Zynger DL, Everton MJ, Dimov ND et al. Expression of glypican-3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol 2008; 130(2): 224–230.

5. Schwartz M, Dvorchik I, Roayaie S et al. Liver transplantation for hepatocellular carcinoma: extensity of indications based on molecular markers. J Hepatol 2008; 49(4): 581–588.

6. Walther Z, Jain D. Molecular Pathology of hepatic neoplasms: classification and clinical significance. Patholog Res Int 2011 : 403929.

7. Bioulac-Sage P, Blanc JF, Rebouissou S et al. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 2007; 13(19): 2649–2654.

8. Makhlouf HR, Ishak KG, and Goodman ZD. Epitheloid hemangioendothelioma of the liver. Cancer 1999; 85(3): 562–582.

9. Mehrabi A, Kashfi A, Fonouni H et al. Primary malignant hepatic epitheloid hemangioendothelioma. A comprehensive review of the literature with emphasis on the surgical therapy. Cancer 2006; 107(9): 2108–2121.